Structurally distinct toxicity inhibitors bind at common loci on β‐amyloid fibril
Open Access
- 29 September 2010
- journal article
- research article
- Published by Wiley in Protein Science
- Vol. 19 (12), 2291-2304
- https://doi.org/10.1002/pro.509
Abstract
The accumulation of aggregated β‐Amyloid (Aβ) in the brain is a hallmark of Alzheimer's disease and is thought to play a role in the neurotoxicity associated with the disease. The mechanism by which Aβ aggregates induce toxicity is uncertain. Nonetheless, several small molecules have been found to interact with Aβ fibrils and to prevent their toxicity. In this paper we studied the binding of these known toxicity inhibitors to Aβ fibrils, as a means to explore surfaces or loci on Aβ aggregates that may be significant in the mechanism of action of these inhibitors. We believe knowledge of these binding loci will provide insight into surfaces on the Aβ fibrils important in Aβ biological activity. The program DOCK was used to computationally dock the inhibitors to an Aβ fibril. The inhibitors docked at two shared binding loci, near Lys28 and at the C‐termini near Asn27 and Val39. The docking predictions were experimentally verified using lysine specific chemical modifications and Aβ fibrils mutated at Asn27. We found that both Congo red and Myricetin, despite being structurally different, bound at the same two sites. Additionally, our data suggests that three additional Aβ toxicity inhibitors may also bind in one of the sites. Identification of these common binding loci provides targets on the Aβ fibril surface that can be tested in the future for their role in Aβ biological activity.Funding Information
- NIH (NS042868)
- NSF CBET (0828009)
This publication has 69 references indexed in Scilit:
- Seeded growth of β-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structureProceedings of the National Academy of Sciences of the United States of America, 2009
- Kinetic study of β-amyloid residue accessibility using reductive alkylation and mass spectrometryBiotechnology & Bioengineering, 2009
- Structural Differences between Aβ(1-40) Intermediate Oligomers and Fibrils Elucidated by Proteolytic Fragmentation and Hydrogen/Deuterium ExchangeBiophysical Journal, 2009
- Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrilsProceedings of the National Academy of Sciences of the United States of America, 2008
- Structural Classification of Toxic Amyloid OligomersOnline Journal of Public Health Informatics, 2008
- Conformer Selection and Induced Fit in Flexible Backbone Protein–Protein Docking Using Computational and NMR EnsemblesJournal of Molecular Biology, 2008
- Congo red and protein aggregation in neurodegenerative diseasesBrain Research Reviews, 2007
- Binding of amyloid β-peptide to ganglioside micelles is dependent on histidine-13Biochemical Journal, 2006
- Experimental Constraints on Quaternary Structure in Alzheimer's β-Amyloid FibrilsBiochemistry, 2005
- UCSF Chimera?A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004